About this trial
Systemic lupus erythematosus is a complex systemicautoimmune disease that can affect most organs of the human body.
Although they are many recommendations on the diagnosis and managment of SLE, diagnosis and therapeutic managment is still challenging.
A pluridisciplinary consultation grouping rheumatologist, nephrologist, dermatologist, gynecologist, internist and immunologists has been set up in 2009 at the university hospital of Brest.
The investigators would like to identify in a longitudinal cohort the occurrence of the different clinico-biological and immunological patterns of systemic lupus erythematosus patients during our multidisciplinary consultation.
It is now crucial to organize a standardized data collection of these patients in order to evaluate our pratices, to be able to study the epidemiology of SLE in our city, and to promote this initiative at national and international level.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any patient over 18 years old of the multidisciplinary consultation
Disqualifiers
Opposition of patient
Trial population
Patients of the systemic lupus erythematous's multidisciplinary consultation at Brest CHRU
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Cohort data
Prevalence and incidence of the clinico-biological and immunological patterns in a longitudinal cohort present in the standardized collection book including evaluation of différents criteria aspects : SLICC criteria
Cohort data
Prevalence and incidence of the clinico-biological and immunological patterns in a longitudinal cohort present in the standardized collection book including evaluation of différents criteria aspects : SLEDAI score
Cohort data
Prevalence and incidence of the clinico-biological and immunological patterns in a longitudinal cohort present in the standardized collection book including evaluation of différents criteria aspects : SDI score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.